Matthias Bodenstedt insider trades: MoonLake Immunotherapeutics (MLTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthias reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | MLTX | ↓ Sell | 39,120 | $22.04 | $862K | Direct | Jun 23, 2026 (1d) |
| Jun 18, 2026 | MLTX | ↓ Sell | 17,876 | $19.67 | $352K | Direct | Jun 18, 2026 (0d) |
| May 11, 2026 | MLTX | ↓ Sell | 13,653 | $20.02 | $273K | Direct | May 13, 2026 (2d) |
| Apr 14, 2026 | MLTX | ↓ Sell | 2,426 | $19.56 | $47K | Direct | Apr 16, 2026 (2d) |
| Apr 10, 2026 | MLTX | ↓ Sell | 87,795 | $18.95 | $1.7M | Direct | Apr 10, 2026 (0d) |
| Oct 8, 2025 | MLTX | ↑ Buy | 10,870 | $9.09 | $99K | Direct | Oct 9, 2025 (1d) |
| Dec 20, 2023 | MLTX | ↓ Sell | 100,000 | $59.17 | $5.9M | Direct | Dec 21, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLTX insiders
Open-market trades in the last 12 months
About Matthias Bodenstedt's insider trades
Matthias Bodenstedt is Chief Financial Officer at MoonLake Immunotherapeutics (MLTX). Since Dec 20, 2023, Matthias has reported 1 open-market purchase worth $99K and 6 sales worth $9.1M on SEC Form 4. In the last 12 months: 5 sales ($3.2M).
Their filings also include shares returned to the company (3 filings), conversions (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.